Nintedanib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nintedanib
Treatment and conditionWhere it standsTrials
Nintedanib for epistaxisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nintedanib for telangiectasia, hereditary hemorrhagicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1